Quick Answer
Alto Neuroscience, Inc. reported Diluted EPS of $2.19 per share (loss) for fiscal year 2025.
Alto Neuroscience, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.19 | +12.4% |
| 2024 | -$2.50 | +74.3% |
| 2023 | -$9.73 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.52 | +16.1% | +20.0% |
| June 30, 2025 | -$0.65 | -8.3% | -16.1% |
| March 31, 2025 | -$0.56 | +26.3% | +9.7% |
| September 30, 2024 | -$0.62 | +74.6% | -3.3% |
| June 30, 2024 | -$0.60 | +74.2% | +21.1% |
| March 31, 2024 | -$0.76 | +61.4% | +68.9% |
| September 30, 2023 | -$2.44 | — | -4.7% |
| June 30, 2023 | -$2.33 | — | -18.3% |
- Alto Neuroscience, Inc. showed an increase of +12.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Alto Neuroscience, Inc.’s diluted eps has grown by 77.5% (from $9.73 per share (loss) to $2.19 per share (loss)).
- The most recent figure is from Alto Neuroscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: